Hang Yang

19PUBLICATIONS
22CO-AUTHORS
Pharmaceutical delivery technologiesMedical infection agents (incl. prions)Industrial molecular engineering of nucleic acids and proteinsHost-parasite interactionsNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 22, 2026
Antibodies targeting phage fiber and nozzle proteins impair Acinetobacter baumannii phage therapy by blocking infection and promoting immune clearance.

|Jul 09, 2025
Host protein ARF1 is a proviral factor for SARS-CoV-2 and a candidate broad-spectrum therapeutic target.

Cunhuan Zhang, Yuan-Qin Min, Heng Xue

|Nov 26, 2024
Dimer-monomer transition defines a hyper-thermostable peptidoglycan hydrolase mined from bacterial proteome by lysin-derived antimicrobial peptide-primed screening.

Li Zhang, Fen Hu, Zirong Zhao

|May 25, 2024
Phage-Bacterial Interaction Alters Phenotypes Associated with Virulence in Acinetobacter baumannii.

Greater Kayode Oyejobi, Xiaoxu Zhang, Dongyan Xiong

|May 07, 2024
Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers.

Di Yin, Yiye Zhong, Sikai Ling

|Apr 10, 2024
Developing nucleoside tailoring strategies against SARS-CoV-2 via ribonuclease targeting chimera.

Yuanqin Min, Wei Xiong, Wei Shen

Pageof 4

Frequent Collaborators

10 joint publications

Hongping Wei

3 joint publications

Yuhong Li

3 joint publications

Raphael Nyaruaba

3 joint publications

Jin He